Guidelines for the management of rheumatoid arthritis: 2002 update - American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines

C. Kent Kwoh, Larry G. Anderson, Jerry M. Greene, Dorothy A. Johnson, James R. O'Dell, Mark L. Robbins, W. Neal Roberts, Robert W. Simms, Robert A. Yood

Research output: Contribution to journalArticle

1227 Citations (Scopus)

Abstract

RA is a chronic progressive polyarthritis (with varying systemic features) associated with substantial disability and economic losses. Successful treatment to limit joint damage and functional loss requires early diagnosis and timely initiation of disease-modifying agents. The goal of treatment is to arrest the disease and to achieve remission. Although remission occurs infrequently, patients may benefit from nonpharmacologic, pharmacologic, and if necessary, surgical interventions. Optimal longitudinal treatment requires comprehensive coordinated care and the expertise of a number of health care providers. Essential components of management include systematic and regular evaluation of disease activity, patient education/rehabilitation interventions, use of DMARDs, possible use of local or low-dose oral glucocorticoids, minimization of the impact on the individual's function, assessment of the adequacy of the treatment program, and general health maintenance.

Original languageEnglish (US)
Pages (from-to)328-346
Number of pages19
JournalArthritis and rheumatism
Volume46
Issue number2
DOIs
StatePublished - Feb 20 2002

Fingerprint

Rheumatoid Arthritis
Guidelines
Antirheumatic Agents
Patient Education
Therapeutics
Health Personnel
Glucocorticoids
Arthritis
Early Diagnosis
Rehabilitation
Joints
Economics
Health

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Pharmacology (medical)

Cite this

Guidelines for the management of rheumatoid arthritis : 2002 update - American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. / Kwoh, C. Kent; Anderson, Larry G.; Greene, Jerry M.; Johnson, Dorothy A.; O'Dell, James R.; Robbins, Mark L.; Roberts, W. Neal; Simms, Robert W.; Yood, Robert A.

In: Arthritis and rheumatism, Vol. 46, No. 2, 20.02.2002, p. 328-346.

Research output: Contribution to journalArticle

Kwoh, C. Kent ; Anderson, Larry G. ; Greene, Jerry M. ; Johnson, Dorothy A. ; O'Dell, James R. ; Robbins, Mark L. ; Roberts, W. Neal ; Simms, Robert W. ; Yood, Robert A. / Guidelines for the management of rheumatoid arthritis : 2002 update - American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. In: Arthritis and rheumatism. 2002 ; Vol. 46, No. 2. pp. 328-346.
@article{e38e5c5a101a4cc7b020f68a739d9220,
title = "Guidelines for the management of rheumatoid arthritis: 2002 update - American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines",
abstract = "RA is a chronic progressive polyarthritis (with varying systemic features) associated with substantial disability and economic losses. Successful treatment to limit joint damage and functional loss requires early diagnosis and timely initiation of disease-modifying agents. The goal of treatment is to arrest the disease and to achieve remission. Although remission occurs infrequently, patients may benefit from nonpharmacologic, pharmacologic, and if necessary, surgical interventions. Optimal longitudinal treatment requires comprehensive coordinated care and the expertise of a number of health care providers. Essential components of management include systematic and regular evaluation of disease activity, patient education/rehabilitation interventions, use of DMARDs, possible use of local or low-dose oral glucocorticoids, minimization of the impact on the individual's function, assessment of the adequacy of the treatment program, and general health maintenance.",
author = "Kwoh, {C. Kent} and Anderson, {Larry G.} and Greene, {Jerry M.} and Johnson, {Dorothy A.} and O'Dell, {James R.} and Robbins, {Mark L.} and Roberts, {W. Neal} and Simms, {Robert W.} and Yood, {Robert A.}",
year = "2002",
month = "2",
day = "20",
doi = "10.1002/art.10148",
language = "English (US)",
volume = "46",
pages = "328--346",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "2",

}

TY - JOUR

T1 - Guidelines for the management of rheumatoid arthritis

T2 - 2002 update - American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines

AU - Kwoh, C. Kent

AU - Anderson, Larry G.

AU - Greene, Jerry M.

AU - Johnson, Dorothy A.

AU - O'Dell, James R.

AU - Robbins, Mark L.

AU - Roberts, W. Neal

AU - Simms, Robert W.

AU - Yood, Robert A.

PY - 2002/2/20

Y1 - 2002/2/20

N2 - RA is a chronic progressive polyarthritis (with varying systemic features) associated with substantial disability and economic losses. Successful treatment to limit joint damage and functional loss requires early diagnosis and timely initiation of disease-modifying agents. The goal of treatment is to arrest the disease and to achieve remission. Although remission occurs infrequently, patients may benefit from nonpharmacologic, pharmacologic, and if necessary, surgical interventions. Optimal longitudinal treatment requires comprehensive coordinated care and the expertise of a number of health care providers. Essential components of management include systematic and regular evaluation of disease activity, patient education/rehabilitation interventions, use of DMARDs, possible use of local or low-dose oral glucocorticoids, minimization of the impact on the individual's function, assessment of the adequacy of the treatment program, and general health maintenance.

AB - RA is a chronic progressive polyarthritis (with varying systemic features) associated with substantial disability and economic losses. Successful treatment to limit joint damage and functional loss requires early diagnosis and timely initiation of disease-modifying agents. The goal of treatment is to arrest the disease and to achieve remission. Although remission occurs infrequently, patients may benefit from nonpharmacologic, pharmacologic, and if necessary, surgical interventions. Optimal longitudinal treatment requires comprehensive coordinated care and the expertise of a number of health care providers. Essential components of management include systematic and regular evaluation of disease activity, patient education/rehabilitation interventions, use of DMARDs, possible use of local or low-dose oral glucocorticoids, minimization of the impact on the individual's function, assessment of the adequacy of the treatment program, and general health maintenance.

UR - http://www.scopus.com/inward/record.url?scp=0036169930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036169930&partnerID=8YFLogxK

U2 - 10.1002/art.10148

DO - 10.1002/art.10148

M3 - Article

C2 - 11840435

AN - SCOPUS:0036169930

VL - 46

SP - 328

EP - 346

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 2

ER -